Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.
about
Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophreniaThe oxidative stress may be induced by the elevated homocysteine in schizophrenic patientsTheories of schizophrenia: a genetic-inflammatory-vascular synthesisGenetic Polymorphisms of Glutathione-Related Enzymes (GSTM1, GSTT1, and GSTP1) and Schizophrenia Risk: A Meta-AnalysisGastrodiae Rhizoma (tiān má): a review of biological activity and antidepressant mechanismsNegative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS studyMeta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene PolymorphismsSearch for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stressImplications of lipid biology for the pathogenesis of schizophrenia.Demonstration of an anti-oxidative stress mechanism of quetiapine: implications for the treatment of Alzheimer's disease.Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia.Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.The role of proteomics in depression researchAltered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.Antioxidant defense system and family environment in adolescents with family history of psychosis.Oxidative stress in schizophrenia: an integrated approach.Association of SOD2, a mitochondrial antioxidant enzyme, with gray matter volume shrinkage in alcoholicsImbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative studyAn Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia.Neurobiology of schizophrenia onset.Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with ControlsDiabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanismsSkin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism.Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.Additive effect of MTHFR and GRIN1 genetic polymorphisms on the risk of schizophrenia.Evaluation of antioxidant deficit in schizophreniaOxidative stress and anxiety: relationship and cellular pathways.Proteome analysis of schizophrenia brain tissue.Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.Proteomic approaches to unravel the complexity of schizophrenia.Molecular links between mitochondrial dysfunctions and schizophrenia.The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways.Psychiatric disorders biochemical pathways unraveled by human brain proteomics.
P2860
Q21562668-3FD8EAA8-2B83-49C0-99CE-F46D00B8FEE5Q24602246-D0FDBD7C-144F-4F4B-9A92-8DB59798618CQ24800460-D7F6E0C4-8D2C-4761-8E1E-9F8A02055208Q26795761-4EF199DF-24A8-4492-9510-01B6000E20E5Q27006845-184AD810-0AE9-45C5-B7EB-185564B7E233Q28472479-711EE953-C422-4708-9E6A-CC5C2906F960Q28547892-F4F0C9A9-22D0-4A89-89D0-BA2A046B5EFEQ30009461-1EDB5FA8-7968-46CE-9A05-8E8EEF45E891Q30371274-9D5ECECF-BA8D-424F-AA31-EA728FAEC210Q30697695-5AD4E181-E93D-4436-8939-E012CE45399BQ33343685-3E4C282F-C903-40D2-B197-D68E66AEB8FEQ33350202-4CD1B917-56AC-497A-B213-14667D0BAFE0Q33589462-63185464-2F55-4E68-8222-254A13E7DE60Q33904833-2057A09A-44BC-4230-871D-D742FD15C330Q33932502-22964B09-11A4-4E04-9DDB-B3CB4A54C3D0Q34130553-0B393D31-6E91-4725-8D12-6419C0FF37C3Q34192207-1B81F5D5-FEDA-41C1-8DBC-07669F5A67E6Q34322948-52984DCC-6DFC-4E4D-B18A-5DD9792E381FQ34351848-BBE3194E-6EBF-44E4-9F69-C165893449ECQ34479923-B4079B0D-10A2-4D38-9C5E-ADCA57DD9875Q34494844-6DED952D-DB8F-4A1A-AE22-EC766E6A6664Q34660749-19A6F194-192D-43AD-AE33-998970E2DF17Q35166850-875A177A-24CE-4146-AE2E-3CADA1DAD4BBQ35579197-36A09081-7661-4D41-A292-D6248923A7D6Q35660832-C51C8A17-B3C5-4010-A2AA-5DD522146E81Q36508050-361E38A2-5385-45DA-BBB3-437A7249C3DCQ36743314-5BA0205B-6E82-47A9-8679-2445E522255DQ36857761-77FD66A8-6279-4964-8AB1-F33CB76C07C3Q36940022-191069AE-1E76-47F5-AEFF-1FBC3B11CF6BQ37054253-9EED222E-558C-428B-9AA9-7432A1A30872Q37248739-BB99B926-28FF-442F-A9A7-E90BF9774886Q37351067-085B1DD2-B8A1-4C68-A199-7CBD9CA3DDF8Q37390287-BAC60E83-8C03-43A6-A04C-2356F5F211E7Q37682924-179F40BB-5FAE-40DF-9253-8DE141FF9BB1Q37699340-6CF3733B-59FA-4165-8C85-D1470D16F77AQ37980246-638A8041-90E0-46FB-8DB7-205DD8488D27Q37987449-ED1E53B2-A3B1-43BA-B64E-C8BF0094AA8FQ38233270-FCB74B28-269A-46E9-BF82-5E1021E2A75AQ38783169-4141BD15-792F-49DF-B66D-A0F14B8615D6Q38885740-2FF12E6F-60B0-46C2-809C-B7D288DFCB30
P2860
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oxidative damage and schizophr ...... its therapeutic implications.
@ast
Oxidative damage and schizophr ...... its therapeutic implications.
@en
Oxidative damage and schizophr ...... its therapeutic implications.
@nl
type
label
Oxidative damage and schizophr ...... its therapeutic implications.
@ast
Oxidative damage and schizophr ...... its therapeutic implications.
@en
Oxidative damage and schizophr ...... its therapeutic implications.
@nl
prefLabel
Oxidative damage and schizophr ...... its therapeutic implications.
@ast
Oxidative damage and schizophr ...... its therapeutic implications.
@en
Oxidative damage and schizophr ...... its therapeutic implications.
@nl
P2093
P1433
P1476
Oxidative damage and schizophr ...... its therapeutic implications.
@en
P2093
P304
P356
10.2165/00023210-200115040-00004
P577
2001-01-01T00:00:00Z
P5875
P6179
1025269086